FDA DEVICE FACTS
SMR Modular Glenoid
Lima Corporate S.P.A.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The SMR Modular Glenoid and liner is intended fo r use in total primary or revision shoulder joint replacement with the SMR Anatomic Shoulder System. The SMR Anatomic Shoulder System is indicated for patients suffering from disability due to: Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis; Inflammatory degenerative joint disease such as rheumatoid arthritis; Treatment of acute fractures of the humeral head that cannot be treated with other fracture fixation methods; Revision of a failed primary implant; Cuff tear arthropathy (CTA Heads only). The SMR Metal Backed Glenoid/Liner construct when used as part of the SMR Anatomic Shoulder Replacement, is intended for use with bone cement and should be used without bone screws.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。